Pharma Research Bio holds investor relations session at Korea Exchange KRX conference hall
Bitget2026/10/06 09:41Pharma Research Bio held an investor relations briefing on Oct. 6, 2026, at the Korea Exchange conference hall in Seoul. Presentation covered company overview, recent operating developments, business outlook, followed by a Q&A session. Audience included analysts, institutional investors, venture capital firms, and other KONEX market participants. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Research Bio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006600731), on October 06, 2026, and is solely responsible for the information contained therein.
- Pharma Research Bio held an investor relations briefing on Oct. 6, 2026, at the Korea Exchange conference hall in Seoul.
- Presentation covered company overview, recent operating developments, business outlook, followed by a Q&A session.
- Audience included analysts, institutional investors, venture capital firms, and other KONEX market participants.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Updated version 2 - PepsiCo will cut some jobs in North America
Sector Update: Financial Stocks Rise Late Afternoon
Data: Arbitrum stablecoin DEX trading volume increased by $64.2 million in the past 7 days
Crypto prices
More
